Jam

  • IQSTEL’s GlobeTopper Acquisition Fuels Rapid Global Fintech Expansion, Accelerating $1 Billion Growth Plan

    IQSTEL Inc. announced an agreement to acquire a 51% stake in fintech innovator GlobeTopper, aiming to expand its global footprint and reach a $1 billion revenue goal by 2027. The acquisition, valued up to $700,000, will leverage GlobeTopper’s projected $65 million in 2025 revenue and existing client base across the Americas, Europe, and Africa, integrating its operations in the IQSTEL’s Fintech Division.

    2025年5月29日
  • FHLBank Atlanta and Synovus Bank Grant $500,000 to Georgia Heirs Property Law Center Inc.

    FHLBank Atlanta and Synovus Bank are providing a $500,000 grant to the Georgia Heirs Property Law Center to address heirs’ property issues and promote generational wealth. This initiative is part of a larger $5.9 million program focused on helping families secure property rights and preserve inheritances, combating the significant challenge of unclear legal documentation in property ownership. The program is crucial, given that nearly half of homeowners lack estate plans, as highlighted by a recent survey.

    2025年5月29日
  • Progyny Welcomes Healthcare Leader Elizabeth Bierbower to Board

    Progyny, a leader in women’s health and family-building benefits, appointed Elizabeth Bierbower to its Board of Directors. This strategic move aims to leverage Bierbower’s three decades of healthcare experience, including leadership roles at Friday Health Plans and Humana, to support Progyny’s growth. The appointment reflects Progyny’s expansion plans and commitment to providing comprehensive solutions, focusing on improved outcomes and reduced costs.

    2025年5月29日
  • Biohaven Initiates Phase 2/3 Trial for Early Parkinson’s Disease, Testing Brain-Penetrant TYK2/JAK1 Inhibitor Against Neuroinflammation

    Biohaven launched a global Phase 2/3 trial for BHV-8000, a first-in-clinic, brain-penetrant TYK2/JAK1 inhibitor, targeting neuroinflammation in Parkinson’s disease. The drug aims to address the underlying cause of disease progression, with no existing disease-modifying therapies currently available. The trial will enroll 550 patients across 13 countries to assess efficacy and safety, utilizing innovative endpoints. BHV-8000 has shown safety and tolerability, with robust brain penetration, representing a potential breakthrough in treating neurodegenerative diseases.

    2025年5月29日
  • Ping An’s Maternal Needlework Initiative Featured at London Craft Week

    Ping An is showcasing its Mother’s Needlework program at London Craft Week 2025, highlighting the traditional embroidery and carpet-making skills of ethnic minority women in China. This initiative preserves cultural heritage while empowering women economically through sustainable production. The program uses recycled materials and traditional designs for eco-friendly products, promoting community development and aligning with the demand for sustainable fashion.

    2025年5月29日
  • Nigeria: TotalEnergies to Sell Non-Operated Stake in Bonga Field

    TotalEnergies will sell its 12.5% stake in Nigeria’s OML118 PSC to Shell for $510 million to focus on lower-emission assets. The OML118 asset includes the Bonga field, with the sale expected to reduce TotalEnergies’ Nigerian output by approximately 11,000 barrels of oil equivalent per day in 2024. This move aligns with TotalEnergies’ strategy to streamline its portfolio and concentrate on existing gas and offshore oil projects, including the Ubeta project.

    2025年5月29日
  • Faraday Future Publishes Results of Annual General Meeting

    Faraday Future announced the results of its Annual General Meeting, with shareholders approving key proposals including production of FX vehicles by late 2025. The company received shareholder support for financial health initiatives and strategic plans, including the FX Super One launch. The meeting also included the re-election of the board of directors and approval of share authorization. FF is aiming to have the first FX vehicle on the production line by the close of 2025.

    2025年5月28日
  • 以下是几个可能的英文标题: * Taysha Gene Therapies Announces Pricing for Public Offering of Common Stock and Pre-Funded Warrants * Taysha Gene Therapies Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants * Taysha Gene Therapies Reveals Pricing of Public Offering for Common Stock and Pre-Funded Warrants

    Taysha Gene Therapies (TSHA) announced a public offering to raise approximately $200 million. The offering includes common stock and pre-funded warrants, priced at $2.75 and $2.749 per share respectively. This capital will advance Taysha’s CNS-focused gene therapy programs, targeting diseases like Rett syndrome with its AAV-based therapies. The deal is expected to close around May 30, 2025.

    2025年5月28日
  • Rumble Applauds Trump’s Visa Restrictions on Foreign Censorship

    Rumble, the video platform, supports President Trump and Secretary Rubio’s efforts to restrict visas for those censoring Americans, aligning with its commitment to free speech. This follows Rumble’s lawsuit against a Brazilian Supreme Court Justice, alleging censorship of a US user’s account violating First Amendment rights. The company views the US stance as crucial in defending digital sovereignty and free expression against global overreach.

    2025年5月28日
  • CORRECTION: Streamex and BioSig Appoint Mitch Williams, CFA, as CIO

    BioSig Technologies and Streamex Exchange have appointed Mitch Williams, CFA, as Chief Investment Officer, a move aimed at tokenizing real-world assets, particularly commodities. Williams brings over two decades of capital markets experience, including leadership roles at OppenheimerFunds and Wafra Inc. His expertise will guide Streamex’s commodity market strategy, leveraging blockchain technology to unlock value in the $142.85 trillion global commodity market.

    2025年5月28日